NKAPL
Title: NKAPL (N-Acetyl-L-Aspartyl-L-Glutamate): An Essential Neurometabolite with Far-Reaching Implications
Description:
NKAPL (N-acetyl-L-aspartyl-L-glutamate) is an essential neurometabolite that plays a crucial role in neuronal energy production, axonal integrity, and neurotransmission. It is predominantly localized in neurons and highly concentrated in white matter tracts, where it accounts for approximately 10% of the total free amino acid pool. NKAPL is synthesized from aspartate and N-acetylaspartate (NAA) and is degraded by N-acetyl-aspartylglutamate amidohydrolase (NAALADase).
Associated Diseases:
Dysregulation of NKAPL metabolism has been implicated in several neurological and neuropsychiatric disorders, including:
- Multiple sclerosis: Reduced NKAPL levels in white matter lesions are associated with axonal damage and neuroinflammation.
- Canavan disease: A fatal neurometabolic disorder caused by a deficiency of NAALADase, leading to accumulation of NKAPL and NAA.
- Schizophrenia: Studies suggest that decreased NKAPL levels in the prefrontal cortex may contribute to cognitive and negative symptoms.
- Depression: Animal models of depression have shown reduced NKAPL expression, suggesting its potential role in mood regulation.
Did you Know ?
In multiple sclerosis, the loss of NKAPL in white matter lesions can be as high as 90%, highlighting the severe disruption of neuronal metabolism in this disease.
